Specialized MarketFocus Genactis Ltd specializes in strategic market research for Pharma and Biotech, with emphasis on late-stage oncology, rare and life-limiting diseases, and precision medicine. This highlights opportunities to offer targeted market intelligence, competitive benchmarking, and payer/brand strategy services for oncology and rare-disease portfolios.

Mid-Sized Scale With 11-50 employees and a revenue range of 1M–10M, Genactis sits in a sweet spot for scalable, high-margin research engagements, enabling upsell to larger pharma clients while maintaining agile project delivery.

Digital Presence The tech stack includes WordPress, Shopify, and Microsoft 365, suggesting comfort with online marketing, content-based lead generation, and e-commerce for client-facing materials or services. This indicates potential for targeted inbound campaigns and digital partnerships.

Global-Intake Readiness As a long-time market research provider for life sciences, Genactis is likely accustomed to complex stakeholder coordination and global data needs, creating opportunities to position services around cross-border studies, patient insights, and regulatory-relevant market access analytics.

Growth Opportunities Funding and revenue signals place Genactis as an active player seeking scale. Potential sales avenues include expanding oncology and rare-disease research offerings, launching strategic advisory or; expanding tech-enabled research capabilities and pilot programs for larger pharma clients.